Cwm LLC Boosts Stock Position in HCA Healthcare, Inc. $HCA

Cwm LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 12.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 16,868 shares of the company’s stock after buying an additional 1,893 shares during the quarter. Cwm LLC’s holdings in HCA Healthcare were worth $7,875,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Hixon Zuercher LLC raised its holdings in HCA Healthcare by 4.6% in the 4th quarter. Hixon Zuercher LLC now owns 6,518 shares of the company’s stock worth $3,043,000 after purchasing an additional 288 shares in the last quarter. Childress Capital Advisors LLC raised its stake in HCA Healthcare by 88.9% in the fourth quarter. Childress Capital Advisors LLC now owns 1,751 shares of the company’s stock worth $818,000 after buying an additional 824 shares in the last quarter. San Luis Wealth Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter valued at approximately $212,000. Townsend & Associates Inc lifted its stake in shares of HCA Healthcare by 1.2% in the 4th quarter. Townsend & Associates Inc now owns 42,238 shares of the company’s stock valued at $20,435,000 after purchasing an additional 483 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in HCA Healthcare by 94.4% in the fourth quarter. Farther Finance Advisors LLC now owns 4,269 shares of the company’s stock worth $1,993,000 after purchasing an additional 2,073 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. This trade represents a 8.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last three months. Insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $477.97 on Tuesday. The business has a 50-day simple moving average of $510.59 and a two-hundred day simple moving average of $484.94. HCA Healthcare, Inc. has a fifty-two week low of $314.43 and a fifty-two week high of $556.52. The firm has a market cap of $106.86 billion, a price-to-earnings ratio of 16.84, a price-to-earnings-growth ratio of 1.50 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the previous year, the company earned $6.22 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 30.17 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date was Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Barclays increased their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Robert W. Baird lowered their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. UBS Group raised their price objective on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Jefferies Financial Group increased their target price on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Finally, Leerink Partners increased their price objective on shares of HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $537.36.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.